8-K current report · filed Jul 20, 2026

Personalis, Inc. (PSNL) 8-K Current Report: July 20, 2026

Item 2.02Item 7.01Item EX-99.1PSNL overview

Short answer

Personalis, Inc. (PSNL) filed an 8-K current report with the SEC on July 20, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Proposed Tempus–Personalis merger remains subject to stockholder approval, regulatory clearances, and other closing conditions.

Personalis, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Proposed Tempus–Personalis merger remains subject to stockholder approval, regulatory clearances, and other closing conditions
  • Transaction timing remains uncertain, with risks of delay, termination, or failure to close
  • Expected synergies and combined-company financial benefits remain forward-looking and unguaranteed
  • Investors directed to forthcoming Form S-4, proxy statement/prospectus, and Schedule 13E-3 for transaction terms and risks

Item 7.01 · Regulation FD Disclosure

  • Tempus agreed to acquire Personalis through a two-step merger structure
  • Personalis shareholders face a change from public ownership to a Tempus subsidiary
  • Transaction remains subject to Merger Agreement terms and closing conditions
  • Merger announcement creates potential strategic integration with Tempus’s precision-medicine platform

Item EX-99.1 · Exhibit EX-99.1

  • Tempus agreed to acquire Personalis for $16.25 per share, valuing the transaction at $1.5 billion net of Tempus’ existing ownership
  • 100% stock consideration, with Tempus able to pay up to 50% in cash and exchange ratio capped at 0.3356
  • 6% premium to Friday’s close and 28% premium to Personalis’ unaffected 30-day VWAP
  • Strategic combination adds Personalis’ MRD technology to Tempus’ AI platform, targeting a stated $20 billion MRD market
  • Closing expected late 2026 or early 2027, pending shareholder and regulatory approvals; Q2 preliminary revenue $22.4 million and 10,384 tests, up 33% QoQ

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Personalis, Inc. 8-K filings

Get the next PSNL 8-K as it lands

Follow PSNL for push alerts, or ask the research agent what this filing means.